Global Innovative Platforms Revenue Growth Rates (GIPL), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Global Innovative Platforms Inc.  (OTC: GIPL)
 

GIPL's Revenue Growth by Quarter and Year

Global Innovative Platforms's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

GIPL Revenue (in millions $) FY 2027 FY 2026 FY 2025 FY 2024
4th Quarter September -
3rd Quarter June 0.05
2nd Quarter March 0.11
1st Quarter December 0.03
FY 0.19





GIPL Revenue third quarter 2027 Y/Y Growth Comment
Global Innovative Platforms Inc. in the third quarter 2027 achieved Revenue of $ 0.05 millions compare to recorded in same quarter a year ago.

According to the results reported in the third quarter 2027, Global Innovative Platforms Inc. achieved the best Revenue growth in Medical Equipment & Supplies industry. While Global Innovative Platforms Inc.' s Revenue no change of 0% ranks overall at the positon no. in the third quarter 2027.


GIPL Revenue ( Y/Y Growth %) 2027
 2026 2025 2024
4th Quarter September - - - -
3rd Quarter June - - - -
2nd Quarter March - - - -
1st Quarter December - - - -
FY   - - - -

Financial Statements
Global Innovative Platforms's third quarter 2027 Revenue $ 0.05 millions GIPL's Income Statement
Global Innovative Platforms's third quarter 2026 Revenue $ 0.00 millions Quarterly GIPL's Income Statement


GIPL Revenue (Quarter on Quarter Growth %)

 2027
 2026 2025 2024
4th Quarter September - - - -
3rd Quarter June -53.91 % - - -
2nd Quarter March 266.67 % - - -
1st Quarter December - - - -
FY (Year on Year)   - - - -


Back to GIPL Growth rate Comparisons >> Back to GIPL Growth rate Comparisons >>


Revenue third quarter 2027 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
(Mar 31 2026)   (Jun 30 2026)
Revenue third quarter 2027 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
(Mar 31 2026)   (Jun 30 2026)

Revenue by Quarter for the Fiscal Years 2024, 2025, 2026, 2027

Global Innovative Platforms's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
255 % 101.3 % -52.39 %
(Mar 31 2026)  


GIPL's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2027 Global Innovative Platforms Inc. disclosed fall in Revenue from the second quarter by -53.91% to $ 0.05 millions, from $ 0.11 millions achived in the previous reporting period.

Within Medical Equipment & Supplies industry Global Innovative Platforms Inc. achieved highest sequential Revenue growth. While Global Innovative Platforms's Revenue growth quarter on quarter, overall rank is 0.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #0
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #0
Revenue Q/Q Growth Statistics
High Average Low
255 % 101.3 % -52.39 %
(Mar 31 2026)  


GIPL's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2027 Global Innovative Platforms Inc. disclosed fall in Revenue from the second quarter by -53.91% to $ 0.05 millions, from $ 0.11 millions achived in the previous reporting period.

Within Medical Equipment & Supplies industry Global Innovative Platforms Inc. achieved highest sequential Revenue growth. While Global Innovative Platforms's Revenue growth quarter on quarter, overall rank is 0.


Global Innovative Platforms's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #


Cumulative Revenue growth Comment
In the Jun 30 2026 period, Global Innovative Platforms's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Global Innovative Platforms Inc. achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the Jun 30 2026 period, Global Innovative Platforms's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Global Innovative Platforms Inc. achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 






Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
GIPL's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue fall for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Bio rad Laboratories Inc -0.05%$ -0.046 millions
Seer Inc -0.29%$ -0.289 millions
Dyadic International Inc -0.57%$ -0.568 millions
Teva Pharmaceutical Industries Limited-0.81%$ -0.814 millions
Aytu Biopharma Inc-0.91%$ -0.911 millions
Neuropace Inc -1.32%$ -1.323 millions
Ardent Health Inc -1.40%$ -1.400 millions
Sunshine Biopharma Inc -1.56%$ -1.557 millions
Pacific Biosciences Of California Inc -1.71%$ -1.706 millions
United Therapeutics Corporation-1.92%$ -1.916 millions
Orasure Technologies Inc-1.93%$ -1.930 millions
Pulmonx Corporation-1.93%$ -1.931 millions
Volitionrx Limited-1.97%$ -1.975 millions
Organon and Co -2.26%$ -2.258 millions
Airsculpt Technologies Inc -2.53%$ -2.527 millions
Charles River Laboratories International inc -2.72%$ -2.718 millions
Perrigo Company Plc-3.17%$ -3.171 millions
Zai Lab Limited-3.33%$ -3.333 millions
Vanda Pharmaceuticals Inc -3.92%$ -3.919 millions
Teladoc Health Inc -3.95%$ -3.952 millions
Dentsply Sirona Inc -4.06%$ -4.060 millions
Sanuwave Health Inc -4.18%$ -4.181 millions
Treace Medical Concepts Inc -4.24%$ -4.244 millions
Fortrea Holdings Inc -4.52%$ -4.519 millions
Positron Corporation-6.91%$ -6.907 millions
Standard Biotools Inc -7.05%$ -7.046 millions
Inspire Medical Systems inc -7.32%$ -7.316 millions
Adapthealth Corp -7.50%$ -7.505 millions
China Pharma Holdings Inc-7.55%$ -7.548 millions
Skinhealth Systems Inc -7.68%$ -7.680 millions


About Global Innovative Platforms Revenue Growth Rates (GIPL), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Global Innovative Platforms Inc (CIK 1837774).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001376474-26-000564
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Global Innovative Platforms Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.